| Global cancer control: responding to the growing burden, rising costs and inequalities in access GW Prager, S Braga, B Bystricky, C Qvortrup, C Criscitiello, E Esin, ... ESMO open 3 (2), e000285, 2018 | 276 | 2018 |
| Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers J Tabernero, M Vyas, R Giuliani, D Arnold, F Cardoso, PG Casali, ... ESMO open 1 (6), e000142, 2016 | 154 | 2016 |
| The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate MC Garassino, M Vyas, EGE De Vries, R Kanesvaran, R Giuliani, ... Annals of oncology 32 (5), 579-581, 2021 | 94 | 2021 |
| Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology R Giuliani, J Tabernero, F Cardoso, KH McGregor, M Vyas, EGE De Vries ESMO open 4 (2), e000460, 2019 | 61 | 2019 |
| Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough? A Eniu, NI Cherny, M Bertram, S Thongprasert, JY Douillard, G Bricalli, ... ESMO open 4 (4), e000483, 2019 | 40 | 2019 |
| Data protection and research in the European Union: a major step forward, with a step back PG Casali, M Vyas Annals of Oncology 32 (1), 15-19, 2021 | 17 | 2021 |
| Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open. 2018; 3 (2): e000285 GW Prager, S Braga, B Bystricky, C Qvortrup, C Criscitiello, E Esin, ... | 16 | |
| Preparing for the incoming wave of biosimilars in oncology E Wolff-Holz, JG Burgos, R Giuliani, G Befrits, J De Munter, L Avedano, ... ESMO open 3 (6), e000420, 2018 | 12 | 2018 |
| COVID-19 vaccination in cancer patients: ESMO statements MC Garassino, M Vyas, EGE de Vries, R Giuliani, S Peters URL https://www. esmo. org/covid‐19‐and‐cancer/covid‐19‐vaccination (last …, 2021 | 7 | 2021 |
| Current models, challenges and best practices for work conducted between European academic cooperative groups and industry RA Stahel, D Lacombe, F Cardoso, PG Casali, A Negrouk, R Marais, ... ESMO open 5 (2), e000628, 2020 | 7 | 2020 |
| Shortages of inexpensive essential medicines M Vyas, EGE de Vries, PG Casali, J Tabernero The Lancet Oncology 20 (5), e224-e225, 2019 | 7 | 2019 |
| Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open. 2017 Jan; 1 ((6)): e000142 J Tabernero, M Vyas, R Giuliani, D Arnold, F Cardoso, PG Casali | 2 | |
| Global cancer control GW Prager, S Braga, B Bystricky, C Qvortrup, C Criscitiello, E Esin, ... ESMO Open 3 (2), 2018 | | 2018 |
| Volume 32-No. 5-May 2021 MC Garassino, M Vyas, EGE de Vries, R Kanesvaran, PA Philip, ... | | |
